Report DMCA Development of [ 89 Zr]DFO-elotuzumab for immunoPET imaging of CS1 in multiple myeloma
* Please fill this form as much details as possible, we will respond to your request within 2 to 3 business days.
* Please fill this form as much details as possible, we will respond to your request within 2 to 3 business days.